How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

NCERT Books for Class 10 Hindi: The latest NCERT Books for Class 10 Hindi have been revised according to the rationalised CBSE syllabus 2025–26. These updated books are the most authentic and ...

SBS Spice breaks new ground with English language content for young Australians of South Asian heritage. It's a fresh new look at pop culture, identity, food, sport, history and much more. The SBS ...

CEBU CITY, Philippines — With the holidays approaching, the Department of Health (DOH) highlighted the common factors that can cause temporary feelings of sadness and anxiety during the festive season ...